Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update May 13, 2026 07:30AM
Arbutus receives FDA fast track status for hepatitis B drug imdusiran Apr 15, 2026 07:30AM
Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B Apr 15, 2026 07:30AM
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update Mar 23, 2026 07:30AM
Arbutus Reports Third Quarter 2025 Financial Results and Provides Corporate Update Nov 13, 2025 07:30AM


Aug 6, 2025 07:30AM Arbutus Reports Second Quarter 2025 Financial Results and Provides Corporate Update
May 14, 2025 07:30AM Arbutus Reports First Quarter 2025 Financial Results and Provides Corporate Update
Mar 31, 2025 05:23AM Citizens JMP Reiterates Market Outperform Rating on Arbutus Biopharma (ABUS)
Mar 27, 2025 07:30AM Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update
Nov 6, 2024 07:30AM Arbutus Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Aug 1, 2024 07:30AM Arbutus Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Jul 6, 2018 09:22AM Pre-Open Movers 07/06: (BBOX) (BIIB) (RGSE) Higher; (RGLS) (GCI) (PSMT) Lower (more...)